First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to examine the safety, tolerability and the way the body handles various single and multiple doses of ARC19499 in patients with hemophilia.
Epistemonikos ID: e3e011c70b21e615aef7282feb8be43bd6de3b49
First added on: May 05, 2024